Brain Tumor News!

Note: The comments under each article title are the opinion of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!

06/01/09 Most common brain cancer may originate in neural stem cells        

06/01/09 Pfizer and Celldex Therapeutics Present Update on CDX-110 (PF-04948568) Phase 2 Brain Cancer Studies at 45th Annual ASCO Meeting        

05/28/09 Common Cancer Drug (Avastin) May Increase Risk of Deadly GI Perforations        

05/28/09 Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program        

05/27/09 Amber Alert: Pennsylvania        

05/26/09 Call for support: Senator Kennedy's Cancer Bill (S. 717 called 21st Century Cancer ALERT-        

05/25/09 Treating Untreatable Brain Tumors: FDA Approves New Laser Surgery        

05/25/09 Brain Tumor Talk Radio        

05/24/09 IBTA E-News May 24 2009        

05/22/09 Retrospective analysis of outcomes among more than 1,000 patients with newly diagnosed anaplastic oligodendroglial tumors.        

05/14/09 A placebo-controlled study investigating the dexamethasone-sparing effects of corticorelin acetate in patients with primary or metastatic brain tumors and peritumoral edema.        

05/14/09 ASCO Abstracts now available online!        

05/14/09 A phase II study of chemoradiation followed by adjuvant temozolomide and poly-ICLC in patients with newly diagnosed glioblastoma: 12- and 18-month survival data (NABTT 0501).        

05/14/09 Bevacizumab in combination with radiotherapy plus concomitant and adjuvant temozolomide for newly diagnosed glioblastoma: Update progression-free survival, overall survival, and toxicity.        

05/14/09 Epidermal growth factor receptor variant III (EGFRvIII) vaccine (CDX-110) in GBM.        

05/14/09 Targeting brain tumor stem cells using a bispecific antibody directed against CD133+ and EGFRvIII+.        

05/14/09 A phase I trial of tumor-associated antigen-pulsed dendritic cell immunotherapy for patients with brain stem glioma and glioblastoma.        

05/14/09 A phase I trial of surgical resection with biodegradable carmustine (BCNU) wafer placement followed by vaccination with dendritic cells pulsed with tumor lysate for patients with malignant glioma.        

05/14/09 A phase I evaluation of intravenous TM601 in recurrent glioblastoma: Use of perfusion MRI to monitor antiangiogenic effects.        

---

Displaying Stories 3330 to 3349 of 7806
Previous 20           Next 20